Global Biosynthesis of Cannabinoids Market Overview:
Global Biosynthesis of Cannabinoids Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Biosynthesis of Cannabinoids Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Biosynthesis of Cannabinoids involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biosynthesis of Cannabinoids Market:
The Biosynthesis of Cannabinoids Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Biosynthesis of Cannabinoids Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biosynthesis of Cannabinoids Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Biosynthesis of Cannabinoids market has been segmented into:
Balanced THC And CBD
Cannabidiol Dominant
THC Dominant
By Application, Biosynthesis of Cannabinoids market has been segmented into:
Pain Management
Anxiety Management
Appetite Stimulation
Nausea Management
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biosynthesis of Cannabinoids market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biosynthesis of Cannabinoids market.
Top Key Players Covered in Biosynthesis of Cannabinoids market are:
Hyasynth Biologicals
Amyris Inc
Demetrix
Jazz Pharmaceuticals PLC
Lygos
Renew Biopharma
CB Therapeutics
Canopy Growth Corp
Zymergen Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Biosynthesis of Cannabinoids Market by Type
4.1 Biosynthesis of Cannabinoids Market Snapshot and Growth Engine
4.2 Biosynthesis of Cannabinoids Market Overview
4.3 Balanced THC And CBD
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Balanced THC And CBD: Geographic Segmentation Analysis
4.4 Cannabidiol Dominant
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Cannabidiol Dominant: Geographic Segmentation Analysis
4.5 THC Dominant
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 THC Dominant: Geographic Segmentation Analysis
Chapter 5: Biosynthesis of Cannabinoids Market by Application
5.1 Biosynthesis of Cannabinoids Market Snapshot and Growth Engine
5.2 Biosynthesis of Cannabinoids Market Overview
5.3 Pain Management
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Pain Management: Geographic Segmentation Analysis
5.4 Anxiety Management
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Anxiety Management: Geographic Segmentation Analysis
5.5 Appetite Stimulation
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Appetite Stimulation: Geographic Segmentation Analysis
5.6 Nausea Management
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Nausea Management: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Biosynthesis of Cannabinoids Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 HYASYNTH BIOLOGICALS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 AMYRIS INC
6.4 DEMETRIX
6.5 JAZZ PHARMACEUTICALS PLC
6.6 LYGOS
6.7 RENEW BIOPHARMA
6.8 CB THERAPEUTICS
6.9 CANOPY GROWTH CORP
6.10 ZYMERGEN INC.
Chapter 7: Global Biosynthesis of Cannabinoids Market By Region
7.1 Overview
7.2. North America Biosynthesis of Cannabinoids Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Balanced THC And CBD
7.2.4.2 Cannabidiol Dominant
7.2.4.3 THC Dominant
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Pain Management
7.2.5.2 Anxiety Management
7.2.5.3 Appetite Stimulation
7.2.5.4 Nausea Management
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Biosynthesis of Cannabinoids Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Balanced THC And CBD
7.3.4.2 Cannabidiol Dominant
7.3.4.3 THC Dominant
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Pain Management
7.3.5.2 Anxiety Management
7.3.5.3 Appetite Stimulation
7.3.5.4 Nausea Management
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Biosynthesis of Cannabinoids Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Balanced THC And CBD
7.4.4.2 Cannabidiol Dominant
7.4.4.3 THC Dominant
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Pain Management
7.4.5.2 Anxiety Management
7.4.5.3 Appetite Stimulation
7.4.5.4 Nausea Management
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Biosynthesis of Cannabinoids Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Balanced THC And CBD
7.5.4.2 Cannabidiol Dominant
7.5.4.3 THC Dominant
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Pain Management
7.5.5.2 Anxiety Management
7.5.5.3 Appetite Stimulation
7.5.5.4 Nausea Management
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Biosynthesis of Cannabinoids Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Balanced THC And CBD
7.6.4.2 Cannabidiol Dominant
7.6.4.3 THC Dominant
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Pain Management
7.6.5.2 Anxiety Management
7.6.5.3 Appetite Stimulation
7.6.5.4 Nausea Management
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Biosynthesis of Cannabinoids Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Balanced THC And CBD
7.7.4.2 Cannabidiol Dominant
7.7.4.3 THC Dominant
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Pain Management
7.7.5.2 Anxiety Management
7.7.5.3 Appetite Stimulation
7.7.5.4 Nausea Management
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Biosynthesis of Cannabinoids Scope:
|
Report Data
|
Biosynthesis of Cannabinoids Market
|
|
Biosynthesis of Cannabinoids Market Size in 2025
|
USD XX million
|
|
Biosynthesis of Cannabinoids CAGR 2025 - 2032
|
XX%
|
|
Biosynthesis of Cannabinoids Base Year
|
2024
|
|
Biosynthesis of Cannabinoids Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Hyasynth Biologicals, Amyris Inc, Demetrix, Jazz Pharmaceuticals PLC, Lygos, Renew Biopharma, CB Therapeutics, Canopy Growth Corp, Zymergen Inc..
|
|
Key Segments
|
By Type
Balanced THC And CBD
Cannabidiol Dominant
THC Dominant
By Applications
Pain Management
Anxiety Management
Appetite Stimulation
Nausea Management
|
